Latigo Biotherapeutics logo

Latigo Biotherapeutics

Thousand Oaks, CA

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependence or tolerability.

latigobio.com

Company Details

Founded

2018

Employees

Between 10 - 50 employees

Raised

$150,000,000

Headquarters Location

Thousand Oaks, CA

Public

No

Acquired

No

CEO

Scott WassermanScott Wasserman

Company Collections

These are collections Latigo Biotherapeutics is a part of. Click on the collection name to view similar companies.

Latigo Biotherapeutics' Industries